ArticleHealth science reports2023

High flow nasal oxygen as a "second-line" therapy for COVID-19 patients intolerant to noninvasive ventilation. A retrospective cohort study.

Federico Lionello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.